Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Cancer and Metastasis Reviews

Issue 1/2003

Content (12 Articles)

Introduction: Cancer and health disparities

Otis W. Brawley

Population categorization and cancer statistics

Otis W. Brawley

Head and neck cancer

Steve McMahon, Amy Y. Chen

Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands

Vickie L. Shavers, Linda C. Harlan, Deborah Winn, William W. Davis

Racial differences in lung cancer

Shirish M. Gadgeel, Gregory P. Kalemkerian

Racial differences in genetic factors associated with breast cancer

Foluso O. Ademuyiwa, Olufunmilayo I. Olopade

Socioeconomic factors and breast cancer in black and white Americans

Nahida H. Gordon

Colorectal carcinoma in black and white race

William F. Anderson, Asad Umar, Otis W. Brawley

Prostate cancer in black and white Americans

Sreekanth Reddy, Marc Shapiro, Ronald Morton Jr., Otis W. Brawley

Myeloma and race: A review of the literature

Michael Benjamin, Sreekanth Reddy, Otis W. Brawley

Chronic inflammation as inductor of pro-cancer microenvironment: Pathogenesis of dysregulated feedback control

P.M. Schwartsburd

Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: A possible activation pathway?

Ben Davidson, Iris Goldberg, Walter H. Gotlieb, Juri Kopolovic, Bjørn Risberg, Gilad Ben-Baruch, Reuven Reich

Dec 02
Issue: 3-4/2002
Jun 03
Issue: 2-3/2003

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits